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1  | INTRODUC TION
The cell walls of mycobacteria including the tuberculosis-causing 
Mycobacterium tuberculosis contain distinct long-chain fatty acids 
termed mycolic acids. These α-alkyl, β-hydroxy fatty acids form an 
integral part of the cell wall of mycobacteria, and of other related 
bacteria of the suborder Corynebacterineae, including the genera 
Nocardia, Corynebacterium and Rhodococcus (Marrakchi, Laneelle, & 
Daffe, 2014). Mycolic acids can be found covalently linked to cell 
wall arabinogalactan and as part of the glycolipids' trehalose mono-
mycolate (TMM), trehalose dimycolate and glucose monomycolate. 
They are essential for mycobacterial viability (Marrakchi et al., 2014; 
Nataraj et al., 2015) and virulence and are synthesised by a complex 
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Abstract
The final step in mycolic acid biosynthesis in Mycobacterium tuberculosis is catalysed 
by mycolyl reductase encoded by the Rv2509 gene. Sequence analysis and homology 
modelling indicate that Rv2509 belongs to the short-chain fatty acid dehydrogenase/
reductase (SDR) family, but with some distinct features that warrant its classifica-
tion as belonging to a novel family of short-chain dehydrogenases. In particular, the 
predicted structure revealed a unique α-helical C-terminal region which we dem-
onstrated to be essential for Rv2509 function, though this region did not seem to 
play any role in protein stabilisation or oligomerisation. We also show that unlike the  
M. smegmatis homologue which was not essential for growth, Rv2509 was an essen-
tial gene in slow-growing mycobacteria. A knockdown strain of the BCG2529 gene, 
the Rv2509 homologue in Mycobacterium bovis BCG, was unable to grow following 
the conditional depletion of BCG2529. This conditional depletion also led to a reduc-
tion of mature mycolic acid production and accumulation of intermediates derived 
from 3-oxo-mycolate precursors. Our studies demonstrate novel features of the my-
colyl reductase Rv2509 and outline its role in mycobacterial growth, highlighting its 
potential as a new target for therapies.
K E Y W O R D S
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array of enzymes that includes a mammalian-like Fatty Acid Synthase 
I (FAS-I), and a multienzyme complex of Fatty Acid Synthase-II 
(FAS-II) (Marrakchi et al., 2014). One of the late stages of mycolic acid 
biosynthesis involves the Claisen condensation of a FAS-II-derived 
long meromycolate chain (C42-C62) with a short FAS-I-derived fatty 
acid (C24-C26) to yield α-alkyl, β-keto fatty acid intermediate, cata-
lysed by the polyketide synthase Pks13 (Gande et al., 2004; Portevin 
et al., 2004). The final step in the formation of a mature mycolic acid 
involves the enzymatic reduction of the β-keto group of the product 
of Pks13 to produce α-alkyl, β-hydroxy fatty acids (mature mycolic 
acid). In M. tuberculosis, the reductase required for this final step is 
encoded by Rv2509 (Bhatt, Brown, Singh, Minnikin, & Besra, 2008; 
Lea-Smith et al., 2007). Initial studies in Corynebacterium glutamicum, 
a species that can survive the loss of mycolic acids, indicated that de-
letion of cmrA (NCgl2385), the Rv2509 orthologue, resulted in a strain 
that accumulated the α-alkyl, β-keto fatty acid precursor instead of 
mature mycolic acids (Lea-Smith et al., 2007). Mycolic acid biosyn-
thesis genes are essential in mycobacteria; however, surprisingly, we 
were able to generate a viable mutant of MSMEG4722, the homo-
logue of Rv2509 in the fast-growing Mycobacterium smegmatis (Bhatt 
et al., 2008). Similar to the C. glutamicum NCgl2385 mutant, the M. 
smegmatis MSMEG4722 mutant produced α-alkyl, β-keto fatty acyl 
precursors of mycolic acids (3-oxo-mycolic acid precursors) which 
were transported and esterified to arabinogalactan in the cell wall 
(Bhatt et al., 2008). While the precise knowledge of the substrate for 
Rv2509 is lacking, functional analysis of the preceding enzyme in the 
biosynthetic pathway, Pks13, indicated that, while this polyketide 
synthase primarily catalyses the formation of the α-alkyl, β-keto 
fatty acyl precursor, it also contains enzymatic motifs that facilitate 
the release of the nascent fatty acyl chain and its subsequent trans-
fer to a trehalose residue to produce a trehalose residue esterified 
with the α-alkyl, β-keto fatty acyl precursor of mycolic acid (Gavalda 
et al., 2014). These findings suggest that the trehalose-bound mono 
3-oxo-mycolic acid precursor may likely be the substrate for Rv2509, 
which catalyses its conversion to TMM (Figure 1). In this study, we 
set out to do a detailed study of the amino acid sequence of Rv2509 
with the aim of deducing its structure and functional connections, 
which led to the identification of series of unique sequences, and 
by proxy, novel structural features. We then probed the role of one 
distinct structural feature of the mycobacterial mycolyl reductase in 
vitro by deletion analysis. We also probed the essentiality of Rv2509 
for the growth and viability of the slow-growing M. tuberculosis com-
plex using Mycobacterium bovis BCG.
2  | RESULTS
2.1 | Homologues of M. tuberculosis Rv2509 are 
found across mycolic acid-producing species
While mycolic acids are produced by several species belonging to 
the suborder Corynebacterineae, the biosynthesis of mycolates 
has been studied in detail exclusively in the genera Mycobacterium 
and Corynebacterium. While the two genera share a common set 
of enzymes required for mycolic acid biosynthesis, select differ-
ences also exist. For example, while the meromycolate chains are 
synthesised by a Type-II fatty acid synthase complex in species of 
Mycobacterium, the same function is carried out by a mammalian-like 
Type-I fatty acid synthase in Corynebacterium species (Radmacher 
et al., 2005). Similarly, differences exist in the transport of mycolic 
acids between the two genera (Varela et al., 2012; Yang et al., 2014). 
To investigate whether the reduction of premycolates by an exclu-
sive mycolyl reductase, was an enzymatic process conserved across 
other mycolic acid-producing species, we used the amino acid se-
quence of Rv2509 as a source template for a BLASTp search of ge-
nome sequences of other known mycolic acid-producing bacteria. 
Homologues of Rv2509 were found across the mycolate-producing 
genera (Figure 2). A phylogenetic analysis of Rv2509, its homologues 
in other mycobacteria and in select mycolic acid-producing spe-
cies revealed that mycolyl reductases from Corynebacterial species 
branched early (Supporting information Figure S1). Corynebacteria 
produce relatively short chain mycolic acids (Radmacher et al., 
2005). To test whether mycolyl reductases across the mycolata 
had evolved specificities to accommodate differing chain lengths, 
we transformed the M. smegmatis ΔMSMEG4722 strain with a plas-
mid-containing C. glutamicum mycolyl reductase gene NCgl2385 to 
generate the strain ΔMSMEG4722-CNCgl2385. Mature mycolic acid 
production was restored in the transformed strain, indicating that 
NCgl2385 could reduce M. smegmatis 3-oxo-mycolic acid precur-
sors and consequently fully complement the mutant M. smegmatis 
strain. This outcome suggested that mycolyl reductases across the 
mycolata likely did not evolve specificities for differing chain lengths 
(Figure 3).
2.2 | Predicted structure of M. tuberculosis Rv2509
We attempted to deduce possible functional properties of Rv2509 
using a comparative sequence and structural analysis with proteins 
of known function. Sequence analysis of Rv2509 using the NCBI 
conserved domain database (Marchler-Bauer et al., 2015) catego-
rises the protein as a part of the DltE family of short-chain dehy-
drogenases (cluster COG0300), which are in turn members of the 
cl27753 short-chain dehydrogenase/reductase (SDR) superfamily 
of NAD(P)-dependent oxidoreductases. This is a diverse group, con-
taining over 80,000 unique sequences (Fujisawa, Nagata, & Misono, 
2003). However, despite this diversity, all SDR-superfamilies display 
the classical Rossmann fold typical of NAD+/NADP+-binding pro-
teins and hence can be classified as belonging to the cl21454 family 
of topologically and structurally related proteins.
Next, we screened the peptide sequence of Rv2509 against the 
PDB database to find structural templates for homology model-
ling. The serine dehydrogenase YdfG (UniProt ID P39831; PDB ID 
3ASU/3ASV) (Yamazawa, Nakajima, Mushiake, Yoshimoto, & Ito, 
2011) had the highest identity score; however, structural analysis 
revealed several gaps in the pairwise alignment and the C-terminal 
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region was shorter than that observed in Rv2509, which necessi-
tated additional template input. Therefore, the structures of the four 
highest-scoring experimental SDRs (3ASU/3ASV, 1XG5, 4X54 and 
4BMV) were used in parallel as a basis for comparative homology 
modelling of Rv2509 (Figure 4) using the I-TASSER package (Yang et 
al., 2015) with specific template selection enabled. Notably, while, 
three of the templates yielded models with roughly equivalent 
(confidence) C-scores, the one based on the SDR from Sphingobium 
yanoikuyae (4BMV.pdb; GenBank ID ACB78183.1) stood out with 
the highest C-score of 0.6, indicating a high quality of prediction.
As visualised by the structural alignment (Figure 2) which shows 
the predicted secondary structure elements of Rv2509 aligned to 
its Corynebacterial homologues, the core structure of the Rv2509 
model presents a typical NADP-binding protein Rossmann fold 
(residues 1–235) (Persson, Kallberg, Oppermann, & Jornvall, 2003) 
with seven parallel β-strands forming a central β-sheet, which is 
F I G U R E  1   Proposed reaction catalysed by Rv2509. The putative substrate is trehalose mono-premycolate and the product is trehalose 
monomycolate. The examples shown here is that of a α-mycolic acid from Mycobacterium tuberculosis
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sandwiched between two layers of α-helices—three on each side 
(Figure 4). Although an earlier study has correctly classified Rv2509 
within the short-chain reductase (SDR) superfamily and identified 
crucial sequence signatures such as the potential NAD(H)/NADP(H)-
binding motif and active site in residues 157–161 (Lea-Smith et al., 
2007), it did not include further structural prediction and analysis, 
and was limited in terms of sequences used. We, therefore, sought 
to expand this initial analysis by performing a systematic analysis of 
the Rv2509 orthologues from a wide range of Corynebacterineae to 
represent all known mycolate-producing genera.
We initiated these studies by analysing the cofactor binding 
site. SDRs can be divided into two large families, “Classical” SDRs 
which are around 250 amino acid residues long and “Extended” 
SDRs which contain around 350 residues (Jornvall et al., 1995), 
exhibiting differences in the arrangement of glycine residues 
within the coenzyme binding sites. Coenzyme preference-predic-
tions based on the strong conservation of the signature residues 
(Persson et al., 2003) classified the Rv2509 into the group of the 
NADP(H)-binding SDRs, consistent with its mycolyl reductase 
function. However, it was difficult to categorically allocate Rv2509 
into a specific group of SDRs as the predicted NADP-binding site 
of Rv2509 (G16XXQ19N20I21G22) displays a unique and novel vari-
ation of the (T)-G-X-X-X-G-I-G motif described by Brakoulias and 
Jackson (2004) (Figure 2). The variation seems to be restricted to 
the long-chain mycolates-producing species of Mycobacteriaceae, 
as short-chain mycolates-producing Corynebacteria retain the 
more established G-X-X-X-G-I-G motif. (Figure 2). Key residue po-
sitions in the NADP(H) site suggest that Rv2509 is a cP2 member of 
F I G U R E  2   A structural alignment of the predicted Rv2509 structure from Mycobacterium tuberculosis, with annotated secondary 
structure elements (top) with the sequences of the Mycobacterial and Corynebacterial homologues highlighting the unique sequence 
motifs of the Rv2509 subfamily of SDRs. The GxxQNIG motif along with RR pair identifies a novel NADP(H) binding consensus, limited to 
Mycobacteriaceae (highlighted in yellow). GxxSGIG is the wider consensus seen in the more remotely related Corynebacteria. Similarly, the 
unique Rossmann core-stabilisation signature CANAGT reported here is also restricted to the Mycobacteriaceae (highlighted in yellow) and 
reverts to the more common (C)NNAG(I/F) in the more remote homologues. Active site residues N-G-S-Y-K in alpha-helix 4 and alpha-
helix 5 are preserved throughout the family; however, a unique additional tyrosine residue can be seen to be present in Mycobacteriaceae 
(highlighted in yellow). The C-terminal extension is also uniquely conserved across the wider Corynebacterial species
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the “Classic” SDR family, according to the classification system of 
Persson et al., (Brakoulias & Jackson, 2004), which is further rein-
forced by the presence of two specific discriminator residues, R-R, 
found in positions 41–42 in both Rv2509 and YdfG from Escherichia 
coli (3ASV.pdb), as these residues are associated with coordination 
of the phosphate group of the NADP(H) cofactor. Further anal-
ysis of Rv2509 suggests that it has a Class IV NADP(H)-binding 
site (with consensus [AVIC]-[LIV]-[VIL]-T-G-[ASGC]-X2-[GR]-[ILF]-
G-X6-[LFY] (Hua, Wu, Sargsyan, & Lim, 2014). Thus, our analysis 
firmly places the Rv2509 family within the NADP(H)-binding sub-
family of SDRs.
The active site in SDRs is formed by a tight cleft, lined by α-helix 
4, β-strand 4 and α-helix 5 (Filling et al., 2002; Oppermann et al., 
1997). Rv2509 exhibits the “classical” SDR motif Yx[AS][ST]K in 
α-helix 5 (Y157 and K161 being the central catalytic residues), while 
the GxggxgSS/T motif in β-strand 4 (G137, S144) and the central res-
idue of α-helix 4, N116 (Figure 2) are also instantly recognisable. In 
addition, it is possible that some contact with the substrate may be 
provided by the β-strand 4.
Rather intriguingly, the consensus residues “NNAG” involved in 
the stabilisation of the central β-sheet of the Rossmann fold in the 
“Classical” SDRs and located at the core of the protein are not fully 
conserved in Rv2509 but take the form of a novel “ANAG” sequence 
(see Figure 2). Furthermore, this novel sequence is paired with a 
preceding Cys residue, which is also correlated with the presence 
of a C-terminal Thr (in position 91 in M. tuberculosis). This unique 
“CANAGT” signature makes Rv2509 orthologues in Mycobacteriaceae 
instantly recognisable (Figure 2).
In SDR proteins, the substrate-binding loop links the sixth 
β-sheet with the seventh α-helix and is one of the larger loops. In 
the predicted structure of Rv2509 this loop spans roughly from 
P187 to S214 and appears largely conserved within the mycolic ac-
id-producing species (Figure 2). While the loop's length and po-
sition corresponds closely to the length of the substrate-binding 
loop in both 4BMV (P183-E206) and 3ASV (P178-T208), there 
was little conservation of the loop's sequence relative to Rv2509 
in these and other divergent SDRs (see ConSurf analysis below 
(Ashkenazy et al., 2016); Supporting information Figure S2), sug-
gesting, as expected, major differences in the structure of the sub-
strate for Rv2509.
The most intriguing finding upon the analysis of the Rv2509 
orthologues was that all of them seem to present a C-terminal do-
main which seems to be highly specific to the Corynebacterineae. It 
proved also the most difficult to model reliably, as in the majority 
of the available SDR structural templates, the C-terminal region, 
appears to be either truncated or disorganized. ConSurf mapping 
using the multiple sequence alignment shown in Figure 2 and mul-
tiple sequence alignment based on 150 nonredundant sequences 
of remote SDR homologues revealed that the C-terminus of 
Rv2509 is uniquely a feature of the subfamily of Corynebacteriales 
(Supporting information Figure S3). Both pairwise and multiple se-
quence analyses indicated that the C-terminal region of the 4BMV.
pdb is closely related to Rv2509 and thus can be tentatively used 
as a template for that region. This was further corroborated that 
by comparative modelling (Song et al., 2013) and pure ab-initio 
modelling (Raman et al., 2009), as implemented in the NewRobetta 
server (http://new.robet ta.org). To validate this hypothesis, we 
conducted additional ab initio secondary structure predictions 
of Rv2509 (236–268) using JPred4 (Drozdetskiy, Cole, Procter, & 
Barton, 2015) and PSIPRED (Buchan & Jones, 2019; Jones, 1999). 
Both of these bioinformatics tools supported a high alpha-helical 
propensity of the C-terminal region of Rv2509, suggesting that 
F I G U R E  3   Complementation of the M. smegmatis ΔMSMEG4722 
mutant with the Corynebacterial mycolyl reductase. TLC analysis 
of 14C-labelled mycolic acid methyl esters (MAMEs) isolated from 
different strains. α; α MAMEs, α′; α′ MAMEs, e; epoxy MAMEs, 
O; origin, D, degradation products derived from 3-oxo-mycolate 
precursors. Solvent system; petroleum ether:acetone (95:5, v:v)
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4BMV as a reliable template for the region (Supporting informa-
tion Figure S3). Indeed, the C-terminus of the 4BMV.pdb structure, 
similarly to Rv2509, appears to be extended and is well-structured, 
presenting an α-helical organisation.
2.3 | The extended C-terminal of Rv2509 is 
essential for the function
Mature mycolic acid production could be restored in the M. smegmatis 
ΔMSMEG4722 mutant on complementation with the M. tuberculosis 
orthologue Rv2509 (Bhatt et al., 2008). The mutant strain thus pro-
vided us with a means of identifying residues and domains required 
for Rv2509 function, by assessing the ability of mutated constructs 
of plasmid-borne Rv2509 to complement the ΔMSMEG4722 strain by 
restoring mature mycolic acid biosynthesis. To test if the extended 
C-terminal of Rv2509 was required for function, we generated trun-
cated versions of Rv2509 cloned in the replicative shuttle plasmid 
pMV261 (Stover et al., 1991). Individual plasmids were then introduced 
by electroporation into the M. smegmatis ΔMSMEG4722 mutant and the 
transformed strain analysed for the restoration of mature mycolic acid 
biosynthesis. Deletion of 14 amino acid residues (Ala255-Ser268) from 
F I G U R E  4   Visualisation of the 
predicted structure of Mycobacterium 
tuberculosis Rv2509 monomer. Two 
different orientations are given; side-
view and top-down view towards the 
coenzyme binding site. The protein 
is coloured like a rainbow from blue 
(N-terminus) to red (C-terminus) and 
the main secondary structure elements 
are labelled, as well as the predicted 
C-terminal extension domain is circled in a 
red oval. The location of the key sequence 
and structural motifs discussed in the text 
is also provided
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the C-terminal of Rv2509 resulted in a complete loss of function as 
the strains transformed with the truncated construct failed to restore 
mature mycolic acid biosynthesis in the ΔMSMEG4722 strain (Figure 5; 
ΔMSMEG4722-CRvD1). A construct with a shorter truncation (Tyr262-
Ser268 deleted) also failed to complement the ΔMSMEG4722 strain 
(Figure 5; ΔMSMEG4722-CRvD2). Expression of Rv2509 and truncated 
constructs could be detected by RT-PCR confirming that the loss of 
Rv2509 function was linked to the deletion of the C-terminal residues 
(Supporting information Figure S4). These results demonstrated that 
the C-terminus of Rv2509 spanning terminal residues Ala255-Ser268 
was critical for function. The findings suggested an essential role for 
the unique, C-terminal extension in the activity of Rv2509.
To further query whether this C-terminal extension played a role 
in either protein stability, protecting Rv2509 from degradation, or 
in oligomerisation, we expressed N-terminal His-tagged versions of 
Rv2509 and Rv2509-D1 (Rv2509 with Ala255-Ser268 deleted) in E. 
coli. Western blot analysis of native polyacrylamide gels showed that 
there were no patterns of degradation detected in Rv2509-D1, indi-
cating that the loss of function due to the deletion of this region was 
not related to protein stability (Supporting information Figure S5). 
Furthermore, we did not observe additional slower migrating bands, 
indicating dimerisation (or oligomerisation) of full-length or truncated 
Rv2509. Furthermore, cross-linking Rv2509 with glutaraldehyde did 
not reveal additional slower migrating bands, suggesting that Rv2509 
did not oligomerise in solution (Supporting information Figure S5).
2.4 | Rv2509 is an essential mycobacterial gene
Given the nonessentiality of the mycolyl reductase gene in M. smegma-
tis and prediction of transposon-site hybridisation screens of a slow-
growing M. tuberculosis Rv2509 mutant, we aimed to generate a null 
mutant of Rv2509 in M. tuberculosis using Specialised Transduction 
(Bardarov et al., 2002). Such a mutant would also allow us to test 
the role of the mycolyl reductase in virulence using macrophage and 
mouse models of infection. However, repeated attempts failed to gen-
erate transductants, suggesting that Rv2509 was essential for growth 
in M. tuberculosis. Indeed, subsequent transposon mutagenesis screens 
utilising deep sequencing predicted Rv2509 to be essential for in vitro 
growth of M. tuberculosis (Griffin et al., 2011). We then utilised a pro-
moter replacement strategy to demonstrate the essentiality of Rv2509 
in slow-growing mycobacterial vaccine strain Mycobacterium bovis 
BCG. The Pmyc1 promoter from M. smegmatis engineered to contain 
four tetO operator sites (Korte et al., 2016) was inserted immediately 
upstream of the start codon of BCG2529, the Rv2509 homologue in 
M. bovis BCG-Pasteur, using Specialised Transduction generating the 
strain BCG::PTet-BCG2529. Controlled gene expression of the BCG2529 
gene was achieved using a plasmid-borne synthetic gene (rev-tetR) de-
rived from Tn10 tetR encoding a mutated TetR protein with reversed 
binding affinity to tetO sites upon the binding of tetracycline. The addi-
tion of anhydrotetracycline (ATc) results in the loss of expression.
The addition of ATc resulted in the loss of growth of BCG::PTet-
BCG2529 in broth, indicating that the expression of the gene en-
coding the mycolyl reductase was essential for the in vitro growth 
of slow-growing mycobacteria (Figure 6a). Furthermore, while con-
centrated cultures of BCG::PTet-BCG2529 showed confluent growth 
on 7H10 agar plates, no confluent growth was observed on plates 
containing ATc (Figure 6b). We did observe a few scattered colo-
nies on the ATc-containing plates and these are likely to be sup-
pressors allowing leaky expression of PTet driven BCG2529. These 
results demonstrated that the mycolyl reductase was essential for 
the growth and viability of slow-growing mycobacteria.
2.5 | Conditional depletion of the mycolyl reductase 
results in the loss of mature mycolic acids
The M. smegmatis mycolyl reductase mutant was unable to synthesise 
fully mature mycolic acids and instead produced 3-oxo-mycolate pre-
cursors that were found esterified to the cell wall arabinogalactan and 
to trehalose (Bhatt et al., 2008). These labile precursors gave rise to 
palmitone derivatives following alkali treatment, which were visual-
ised on Thin Layer Chromatography (TLC) plates migrating close to the 
F I G U R E  5   TLC analysis of 14C-labelled MAMEs isolated from 
the strains of M. smegmatis ΔMSMEG4722 mutant transformed 
with the different deletion constructs of Rv2509. α; α MAMEs, α′; 
α′ MAMEs, e; epoxy MAMEs, O; origin, D, degradation products 
derived from 3-oxo-mycolate precursors. Solvent system; 
petroleum ether:acetone (95:5, v:v)
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solvent front in a solvent system used for separating methyl esters of 
mycolic acids and fatty acids (FAMEs and MAMEs) (Bhatt et al., 2008). 
To test the effects of conditional depletion of the mycolyl reductase 
we labelled the cultures of BCG::PTet-BCG2529 with 
14[C]-acetic acid 
following grown in the presence and absence of ATc, and extracted 
MAMEs from the cultures. TLC analysis of the extracted MAMES 
showed a decrease in the levels of α and keto MAMES and an accu-
mulation of the degradation products derived from 3-oxo-mycolate 
precursors close to the solvent front (Figure 7). These results showed 
that, as in M. smegmatis, loss of the mycolyl reductase function led to 
the loss of mature mycolic acid production and accumulation of the 
premature 3-oxo-mycolate precursors in slow grow mycobacteria.
3  | DISCUSSION
As summarised above, the predicted structure of the Rv2509 dis-
plays a Rossmann fold with seven parallel β-strands forming a central 
beta-sheet, which is sandwiched between two layers of alpha-heli-
ces—three on each side (Figure 4). While largely consistent with the 
“classical” family of SDRs (Persson et al., 2003), in Mycobacteriaceae, 
the NADP(H)-binding motif (G-x-x-Q-N-I-G), alongside the core sta-
bilisation consensus (C-A-N-A-G-T) is significantly divergent from 
the consensus, to instantly identify this group of SDRs, and in our 
view is distinct enough to be separated into a distinct family.
While we currently lack knowledge about the exact mode of co-
factor and ligand binding within the Rv2509 family, some informa-
tion could be inferred from the structurally related FabG family of 
β-ketoacyl reductases which are classified as “Complex family SDRs” 
(Persson et al., 2003). Given that the structural overlay of Rv2509 
models with existing ligand-bound FabG members yields an RMSD 
of around 1 Å over the C-alpha backbone atoms, and that FabG share 
common active site residues with Rv2509 it is tempting to suggest 
that these structures share common ligand-binding and NADP(H) 
orientations towards the active site residues with that observed in 
the aceto-acyl-CoAs. Furthermore, the predicted 3D structure of 
Rv2509 also revealed a unique α-helical C-terminal extension, which 
we subsequently showed to be essential for function—constructs 
with deletions in the C-terminal failed to complement (restore my-
colate biosynthesis) in the M. smegmatis mutant.
The role of this C-terminal domain is difficult to assign with cer-
tainty; however, in related SDRs similar C-terminal extensions play 
a number of functions. In the NADP(H)-dependent tetrameric ser-
ine-dehydrogenase YdfG from E. coli (3ASV.pdb) (Yamazawa et al., 
2011), the C-terminal region protrudes from the main core of the 
protein and is required for tetramer formation, while it also plays a 
role in the substrate binding via stabilisation of the substrate loop. It 
is also notable that in FabG family of related SDRs discussed above 
also organise as tetrameric assemblies with the participation of their 
C-terminal domains (Javidpour et al., 2014). Furthermore, in the my-
cobacterial FabG4 dimer, Arg146 and Arg445 of one protomer inter-
act with the C-terminus of the second protomer and play an essential 
role in the substrate association and catalysis (Dutta, Bhattacharyya, 
Roychowdhury, Biswas, & Das, 2013). However, our experiments 
with purified full-length and truncated Rv2509 do not seem to sug-
gest that the mycolyl reductase forms oligomers.
While it isn't in itself surprising that Rv2509 presents a con-
served SDR fold, our analysis has identified it for the first time deci-
sively as a member of the NADPH-binding family and indicated that 
it possesses a number of unique features. Taken together with the 
unique signatures of the NADPH-binding site, core stabilisation do-
mains, as well as C-terminal domain extension, the unique features 
of Rv2509 possibly merit its inclusion into a distinct family.
Our previous studies with M. smegmatis suggested that the my-
colyl reductase would likely not be essential for the growth in M. 
tuberculosis and related slow-growing mycobacteria. However, this 
work demonstrated that gene encoding the reductase, Rv2509, was 
an essential gene required for the growth of slow-growing myco-
bacteria in laboratory media. This, along with the identification of 
unique domains in the predicted structure of Rv2509 highlights its 
potential as a novel anti-TB drug target.
F I G U R E  6   Conditional depletion of the mycolyl reductase 
in BCG::PTet-BCG2529 leads to the loss of growth. (a) growth in 
different concentrations of ATc in 7H9 broth, (b) growth on 7H10 
agar containing 5 µg/ml of ATc. Control strain; BCG transformed 
with pMV261::rev-tetR-RBS-D
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4  | E XPERIMENTAL PROCEDURES
4.1 | Growth conditions, strains, phages and 
plasmids
M. smegmatis mc2155 and derived strains was cultured in Tryptic Soy 
Broth (TSB) or on TSB-agar, M. bovis BCG strains were grown in 7H9 
broth or on 7H10 agar plates. E. coli strains were grown in LB broth 
or LB agar. Hygromycin was used at a concentration of 100 mg/ml 
for E. coli and mycobacterial strains. Kanamycin was used at a con-
centration of 25 mg/ml and 50 mg/ml for mycobacteria and E. coli 
respectively. Recombinant mycobacterial strains, phages and plas-
mid constructs used in this study are listed and described in Table 1.
4.2 | Sequence analysis and homology modelling
The multiple sequence alignments (MSA) were prepared using 
MAFFT and NJ/UPGMA phylogeny algorithms as implemented in 
MAFFT v.7 server (https ://mafft.cbrc.jp/ (Katoh, Misawa, Kuma, & 
Miyata, 2002)) and the resulting phylogenetic trees were visualised 
using Archaeopteryx (Han & Zmasek, 2009). Multiple sequence 
alignment visualisation and structural annotations were performed 
using ESPript 3 (Gouet, Robert, & Courcelle, 2003). For the purposes 
of homology modelling, we employed I-TASSER (Yang et al., 2015) 
with the assignment of templates. Outputs were independently 
corroborated by ab-initio modelling using the New Robetta server 
(http://new.robet ta.org). Sequence conservation analysis was per-
formed using ConSurf (Ashkenazy et al., 2016) and visualised using 
PyMOL (The PyMOL Molecular Graphics System, Version 1.71 
Schrödinger, LLC) with additional local manual refinement and struc-
tural superposition performed in Coot (Emsley, Lohkamp, Scott, & 
Cowtan, 2010). Secondary structure predictions for the C-terminal 
domain were performed with JPred4 (Cole et al., 2008) and PSIPRED 
(Buchan et al., 2013).
4.3 | Expression, purification and analysis of 
Rv2509 and its C-terminal truncated derivative
Rv2509 was cloned in the expression vector pET28a by PCR 
from M. tuberculosis H37Rv genomic DNA using the primer pair 
Pet28a_Rv2509 _F2 (5′-TTTACATATGCCGATA CCCGCGCCC-3′) 
and Pet28a_Rv2509_R1 (5′-ATTAAAGCTTCTAGCTGCCCCCAA 
F I G U R E  7   TLC analysis of 14C-labelled 
MAMEs isolated from BCG::PTet-BCG2529 
strain. α; α MAMEs, keto; keto MAMEs, 
O; origin, D, degradation products derived 
from 3-oxo-mycolate precursors. Solvent 
system; petroleum ether:acetone (95:5, 
v:v)
10  |     JAVID et Al.
GCCTCTTG-3′). Similarly, the C-terminal truncated version 
of Rv2509 (missing the last 14 amino acids) was PCR ampli-
fied using the primer pair Pet28a_Rv2509 _F2 (5′-TTTACATA 
TGCCGATACCCGCGCCC-3′) and Pet28a_Rv2509_delR1 
(5′-ATTAAAGCTTCTACA CGATGGCGCGCGGAGC-3′). The con-
structs were cotransformed into BL21 cells with M. tuberculosis 
chaperone GroES 60.2. Cultures were seeded 1:100 with an over-
night starter culture and grown at 37°C in terrific broth supple-
mented with ampicillin (100 µg/ml) and kanamycin (50 µg/ml) to 
OD600 = 0.6 and induced with 0.5 mM IPTG overnight at 37°C or 
16°C respectively. Cells were harvested at 4,000 rpm at 4°C, washed 
with PBS and frozen at −80°C until further use. Full-length protein 
was purified on cobalt-IMAC in buffer 50 mM NAH2PO4 pH 7.5, 
500 mM NaCl, 10% glycerol and truncated in the same buffer com-
position at pH 7.0. The eluted fraction of 200 mM imidazole was 
taken for native-PAGE analysis.
A native polyacrylamide gel with the separated samples was 
transferred to a Hybond™ nitrocellulose membrane (GE Healthcare 
Life Sciences) which was then blocked in 5% milk 20 mM Tris pH 
7.5, 150 mM NaCl TBS 0.05% Tween for 1h at room temperature 
followed by incubation with 0.1% milk TBS-tween with penta-his 
antibody BSA free (Qiagen). Following washing with TBS-tween the 
membrane was incubated with 0.1% milk TBS-tween with anti-mouse 
IgG-Alkaline Phosphatase (Sigma Aldrich) for 30 min at room tem-
perature, washed with TBS-tween and a final wash with TBS. The 
membrane was stained for 5 min with BCIP/NBT (SIGMAFAST™) in 
water for visualisation.
Cross-linking of full-length Rv2509 was carried out in 50 mM 
NaH2PO4 pH 7.5, 10% glycerol at a final concentration of 0.1% glu-
taraldehyde and allowed to progress at room temperature for 2 min. 
The reaction was halted with 1M Tris pH 8 and subsequently run on 
SDS-PAGE for visualisation using SYPRO-ruby (Molecular Probes).
4.4 | Conditional depletion of the Rv2509 
homologue BCG2529 in M. bovis BCG-Pasteur
For establishing the regulated expression of the BCG2529 gene, a 
synthetic gene cassette (hyg-Pmyc1-4XtetO) comprising a hygromy-
cin-resistance gene and the Pmyc1 promoter from M. smegmatis en-
gineered to contain four tetO operator sites (Korte et al., 2016) was 
inserted immediately upstream of the BCG2529 start codon in M. bovis 
BCG-Pasteur. Targeted gene knock-in was achieved by specialised 
transduction employing temperature-sensitive mycobacteriophages 
essentially as described previously (Korte et al., 2016). Briefly, for the 
generation of an allelic exchange construct for site-specific insertion 
TA B L E  1   Plasmids and bacterial strains used in this study
 Description Reference/Source
Plasmids
pMV261 E. coli-Mycobacterium shuttle plasmid vector with hsp60 promoter and 
KanR cassette (aph)
Stover et al. (1991)
pMV261-Rv2509 Rv2509 cloned in pMV261 Bhatt et al. (2008)
pMV261-NCgl2385 NCgl2385 cloned in pMV261 This work
pMV261-Rv2509D1 Deletion construct of Rv2509 cloned in pMV261 encodes a truncated 
protein missing the C-terminal residues Ala255-Ser268
This work
pMV261-Rv2509D2 Deletion construct of Rv2509 cloned in pMV261 encodes a truncated 
protein missing the C-terminal residues Tyr262-Ser268
This work
pMV261::rev-tetR-RBS-D Episomal E. coli-mycobacterium shuttle plasmid pMV261::rev-tetR-
RBS-D providing constitutive rev-tetR gene expression from the 
HSP60 promoter in mycobacteria
Korte et al. (2016)
pET28a-Rv2509 Plasmid for expressing Rv2509 in E. coli This work
pET28a-Rv2509D1 Plasmid for expressing C-terminal truncated Rv2509 in E. coli This work
Bacterial strains
mc2155 Electroporation-proficient ept mutant of M. smegmatis strain mc26 Snapper, Melton, Mustafa, Kieser, 
and Jacobs (1990)
ΔMSMEG4722 Deletion mutant of mc2155 in which MSMEG4722 is replaced by hyg Bhatt et al. (2008)
ΔMSMEG4722-CRv ΔMSMEG4722-containing pMV261-Rv2509 Bhatt et al. (2008)
ΔMSMEG4722-CNCgl2385 ΔMSMEG4722-containing pMV261-NCgl2385 This work
ΔMSMEG4722-CRvD1 ΔMSMEG4722-containing pMV261-Rv2509D1 This work
ΔMSMEG4722-CRvD2 ΔMSMEG4722-containing pMV261-Rv2509D2 This work
BCG::PTet-BCG2529 BCG Pasteur strain containing the Pmyc1 promoter from M. smegmatis 
engineered to contain four tetO operator sites, inserted immediately 
upstream of the start codon of BCG2529, the BCG homologue of 
Rv2509
This work
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of the hyg-Pmyc1-4XtetO cassette in M. bovis BCG-Pasteur, upstream- 
and downstream DNA regions flanking the BCG2529 start codon 
were amplified by PCR employing the oligonucleotide pairs Mb2537_
LL 5′-TTTTTCCATAAATTGGAACCGCTACCTGACATGAAACCC-3′ 
and Mb2537_LR 5′-TTTTTCCATTTCTTGGGCCGATGTTCTGCGA 
AGCCCCGG-3′ as well as Mb2537_RL 5′-TTTTTCCATAGATTGGAT 
GCCGATACCCGCGCCCAGCCC-3′ and Mb2537_RR 5′-TTTTT 
CCATCTTTTGGCGGTGTGGGAGGAGATACTCAAG-3′ respectively. 
The gene BCG2528c is localised in antilinear orientation upstream 
of BCG2529 with only 84 bp between the start codons of both 
genes. Since it could not be excluded that the Mb2536c promoter 
region might overlap with the BCG2529 coding region, the upstream 
flanking region contained a duplication of 66 bp of the 5′-end of 
BCG2529 to conserve 150 bp in front of BCG2529 that likely com-
prised its promoter. Subsequently, the upstream and downstream 
flanks were digested with Van91I (restriction sites underlined) and 
ligated with Van91I-digested pcRv1327c-4XtetO vector arms (Korte 
et al., 2016). The resulting knock-in plasmid was then linearised 
with PacI and cloned and packaged into the temperature-sensitive 
phage phAE159 (Jain et al., 2014), yielding a knock-in phage which 
was propagated in M. smegmatis at 30°C. Allelic exchange in M. bovis 
BCG-Pasteur using the knock-in phage at the nonpermissive tem-
perature of 37°C was achieved by specialised transduction using 
hygromycin (50 mg/L) for selection, resulting in the site-specific 
insertion of the hyg-Pmyc1-4XtetO cassette. The obtained M. bovis 
c-BCG_2529-4XtetO knock-in mutant was verified by the diagnostic 
PCR of genomic DNA using the oligonucleotide pair BCG_2529_L_
fw 5′ GTCAGGTAGACGGAGAACAC-3′ and BCG_2529_L_rev 5′ 
AGCTCACCGCGCAGAGATTC-3′ binding outside the allelic ex-
change substrates used to generate this mutant and subsequent 
sequencing of PCR products (Supporting information Figure S6). 
For achieving the controlled gene expression of the Mb2537 gene, a 
synthetic gene (rev-tetR) derived from Tn10 tetR encoding a mutated 
TetR protein with reversed binding affinity to tetO sites upon the 
binding of tetracycline (Klotzsche, Ehrt, & Schnappinger, 2009) was 
heterologously expressed in the knock-in mutant by electroporation 
of the episomal E. coli-mycobacterium shuttle plasmid pMV261::rev-
tetR-RBS-D providing constitutive rev-tetR gene expression from 
the HSP60 promoter in mycobacteria using solid medium contain-
ing 50 mg/L of hygromycin and 20 mg/L of kanamycin for selection 
(Famulla et al., 2016). This yielded the conditional mutant BCG-
Pasteur c-BCG2529-4XtetO pMV261::rev-tetR-RBS-D (referred to as 
BCG::PTet-BCG2529) allowing silencing of the BCG2529 gene in the 
presence of anhydrotetracycline (ATc).
For silencing experiments, precultures of the BCG::PTet-
BCG2529 strain were first grown in liquid medium containing 
0.3 µg/ml of ATc, before these precultures were used to inoculate 
the test cultures containing 0–5 µg/ml of ATc. Growth in 96-well 
microtitre plates was quantified after incubation at 37°C for five 
days by adding 10% of 100 µg/ml of resazurin solution. After fur-
ther incubation at ambient temperature for 16 hr, cells were fixed 
for 30 min by formalin addition (5%, v/v, final concentration) and 
fluorescence was quantified using a microplate reader (excitation 
540 nm, emission 590 nm). For the growth on 7H10 agar, nonper-
missive conditions were obtained by adding ATc to a final concen-
tration of 5 µg/ml.
4.5 | Functional complementation studies
Deletion constructs for Rv2509 were generated by PCR amplifi-
cation of selected regions of Rv2509 using pMV261-Rv2509 as 
a template, incorporating a premature stop codon in the reverse 
primer. The plasmid constructs generated in this manner were called 
pMV261-Rv2509D1 and pMV261-Rv2509D2, encoding a truncated 
protein missing the C-terminal residues Ala255-Ser268 and Tyr262-
Ser268 respectively. The C. glutamicum Rv2509 orthologue, NCgl2385 
was PCR amplified using C. glutamicum genomic DNA as a template 
and the PCR product was cloned into pMV261 using primer incor-
porated BamHI and EcoRI sites generating the plasmid pMV261-
NCgl2385. Plasmid clones were electroporated into the M. smegmatis 
ΔMSMEG4722 mutant strain using previously described protocols 
(Snapper et al., 1990). Kanamycin-resistant transformants were cul-
tured in TSB and FAMEs and MAMEs were extracted from the cell 
pellets and separated by TLC as previously described (Vilcheze & 
Jacobs, 2007).
4.6 | RT-PCR of Rv2509 transcripts
M. smegmatis strains were grown to mid-log phase and RNA was ex-
tracted by acid phenol and chloroform extraction. The purified RNA 
was treated with DNase and converted to cDNA, which was used as 
a template for quantitative PCR. PCR products were run on a 1% aga-
rose gel to detect the expression of Rv2509. The gene sigA was moni-
tored as a constitutively expressed gene. The primers used for PCR 
amplification were Rv2509RT-f (5′-ACAAGTACCGCGTCACGGTC 
-3′) and Rv2509RT-r (5′-AAGTCCGGCACC AGCTTCTC-3′) for the 
amplification of nondeleted sections of Rv2509.
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